Cogent Biosciences, Inc. (COGT) vs Definium Therapeutics, Inc. (DFTX)
Cogent Biosciences, Inc. and Definium Therapeutics, Inc. are both Biotechnology companies. Cogent Biosciences, Inc. is the larger, with a market value of $5.5B against $4.9B — 1.1× the size. Across the 9 metrics below, Definium Therapeutics, Inc. leads on 5 and Cogent Biosciences, Inc. on 4.
Valuation
Profitability
| Metric | COGT | DFTX | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (146.55%) | (64.09%) | (57.72%) |
| Return on assets | (68.00%) | (51.35%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack